Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Kosakonia cowanii

ABSTRACT: Whole genome sequencing of Enterobacter cowanii, an opportunistic pathogen

PROVIDER: PRJDB2424 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	DRR015891_1.fastq.gz	Fastqsanger.gz
	DRR015891_2.fastq.gz	Fastqsanger.gz

Items per page:

1 - 2 of 2

Similar Datasets

Project description:Whole genome sequencing of Enterobacter aerogenes, an opportunistic pathogen

| PRJDB2238 | ENA

Project description:Whole genome sequencing of Enterobacter intermedius, an opportunistic pathogen

| PRJDB2452 | ENA

Project description:Whole genome sequencing of Enterobacter turicensis, an opportunistic pathogen

| PRJDB2808 | ENA

Project description:Whole genome sequencing of Enterobacter taylorae, an opportunistic pathogen

| PRJDB2847 | ENA

Project description:Whole genome sequencing of Enterobacter ludwigii, an opportunistic pathogen

| PRJDB2121 | ENA

Project description:Whole genome sequencing of Enterobacter kobei, an opportunistic pathogen

| PRJDB2765 | ENA

Project description:Whole genome sequencing of Enterobacter cloacae subsp. dissolvens, an opportunistic pathogen

| PRJDB2277 | ENA

A multicenter translational biomarker phase II trial of regorafenib in patients with non-resectable pretreated colorectal cancer.

Project description:Primary objectives: The primary objective is to investigate circulating tumor DNA (ctDNA) via deep sequencing for mutation detection and by whole genome sequencing for copy number analyses before start (baseline) with regorafenib and at defined time points during administration of regorafenib for treatment efficacy in colorectal cancer patients in terms of overall survival (OS). Primary endpoints: circulating tumor DNA (ctDNA) via deep sequencing for mutation detection and by whole genome sequencing for copy number analyses before start (baseline) with regorafenib and at defined time points during administration of regorafenib for treatment efficacy in colorectal cancer patients in terms of overall survival (OS).

| 2533916 | ecrin-mdr-crc

Project description:Whole genome sequencing of Aeromonas media, an opportunistic pathogen

| PRJDB2240 | ENA

Project description:Whole genome sequencing of Clostridium histolyticum, an opportunistic pathogen

| PRJDB2661 | ENA